Sulfamerazine (CAS 127-79-7)

Sulfamerazine, a chemical compound, has been a subject of extensive scientific research primarily due to its broad-spectrum antimicrobial activity against various bacterial pathogens. Its mechanism of action involves competitive inhibition of dihydropteroate synthase (DHPS), an enzyme crucial for bacterial folate synthesis. By mimicking the substrate para-aminobenzoic acid (PABA), sulfamerazine competes with PABA for the active site of DHPS, ultimately disrupting the synthesis of tetrahydrofolate, an essential precursor for DNA and RNA synthesis in bacteria. This inhibition leads to impaired nucleic acid synthesis and subsequent bacterial growth inhibition. In research applications, sulfamerazine has been utilized as a tool to study bacterial folate metabolism, enzyme kinetics, and mechanisms of antibiotic resistance. Moreover, it has been investigated for its potential synergistic effects in combination therapy regimens with other antibiotics, aiming to enhance antimicrobial efficacy and overcome bacterial resistance mechanisms. Additionally, research efforts have focused on optimizing sulfamerazine derivatives to improve its pharmacokinetic properties and broaden its spectrum of antimicrobial activity, contributing to advancements in antimicrobial research and the development of novel antibiotics.